Actor Eric Dane died Thursday, February 19, 2026, after what his official Instagram account described as a “courageous battle” with amyotrophic lateral sclerosis (ALS). The post said he spent his final days surrounded by friends, his wife Rebecca and their daughters, Billie and Georgia, who were “the center of his world.”
Dane, 53, had gone public with his ALS diagnosis about 10 months earlier and quickly became an outspoken advocate for awareness and research. He worked with I AM ALS and its Push for Progress campaign to raise funds and expand access to experimental therapies, and he lobbied for extension of the Accelerating Access to Critical Therapies for ALS Act — the 2021 law that provided five years of research funding and early treatment pathways and is due to expire in 2026, according to reporting from CNN.
Best known for his roles as Dr. Mark “McSteamy” Sloan on Grey’s Anatomy and as Cal Jacobs on Euphoria, Dane told People after his diagnosis that he felt fortunate to be able to continue working and had been looking forward to returning to the Euphoria set. His family’s announcement noted, however, that his illness “progressed far more quickly than anyone could have imagined.”
ALS, often called Lou Gehrig’s disease, is a progressive disorder that damages motor neurons — the nerve cells that control voluntary muscles. As neurologist Rab Nawaz Khan, MD, a consultant with MyMSTeam, explained to Healthline, the disease often begins with focal weakness: hand clumsiness, foot drop, tripping, difficulty with buttons or other fine motor tasks, or changes in speech clarity. Many people also notice muscle cramps, twitching (fasciculations), and thinning of muscles in affected areas.
As the condition advances, weakness typically spreads, affecting walking, arm use, speech and swallowing. Eventually the respiratory muscles are involved, producing symptoms such as disrupted sleep, morning headaches and shortness of breath with exertion. Sensation is usually preserved in ALS, so numbness and tingling are not common. A subset of patients may experience changes in thinking, behavior or cognition.
The National Institute of Neurological Disorders and Stroke notes that ALS can occur at any age but is most common between ages 55 and 75. Younger men have a higher risk than younger women, though women’s rates tend to catch up with age. Non-Hispanic white people are diagnosed more often, and there is a poorly understood association between military service and ALS. About 10% of cases are linked to inherited genetic mutations.
There is currently no cure for ALS, but treatments can slow progression for some people and improve comfort and function. Approved disease-targeted drugs include riluzole and edaravone, and a gene-targeted therapy exists for an inherited form associated with the SOD1 mutation. Khan emphasized that coordinated, multidisciplinary care — addressing breathing, nutrition, mobility and communication early — often has the largest effect on quality of life. Noninvasive ventilation can improve sleep, energy and everyday functioning as breathing weakens, and cough-assist devices help clear secretions. Nutrition support, speech and language therapy, augmentative communication devices, physical and occupational therapy, and medications for spasticity, drooling, cramps, mood symptoms or pseudobulbar affect can all reduce daily burdens.
Research into new ALS treatments continues, and Dane’s advocacy helped draw attention and resources to that effort. While the disease ultimately took his life, his public work to raise awareness and support research may accelerate progress for others living with ALS. He is survived by his wife, Rebecca, and their daughters, Billie and Georgia.
